Notch proteins are evolutionarily conserved cell-surface receptors for transmembrane ligands of the DSL family (named after the Delta and Serrate ligands of *Drosophila*) \[[@B1],[@B2]\]. Signaling by Notch regulates a broad range of cell-fate decisions during development and various human diseases, including cancers, have been associated with defects in Notch signaling.

The extracellular part of Notch contains 36 epidermal growth factor-like (EGF) repeats carrying the ligand-binding region and three Lin12/Notch repeats (LNRs) that limit proteolytic cleavage of the receptor at the S2 site, and hence limit its activation \[[@B2]\]. The EGF repeats are modified by two types of *O*-linked glycosylation, *O*-glucosylation and *O*-fucosylation (Figure [1a](#F1){ref-type="fig"}); both are important for Notch activity \[[@B3]-[@B6]\] (Figure [1a](#F1){ref-type="fig"}).

![*O*-fucosylation of Notch and functions of Ofut1. **(a)**Schematic representation of the *Drosophila*Notch receptor. The extracellular domain (NECD) is composed of three Lin12/Notch repeats (LNRs) (black) and 36 EGF-like repeats; the EGF repeats are predicted to be either *O*-glucosylated (cyan), *O*-fucosylated (yellow) or doubly modified (green) adapted from \[19\]. The S2 cleavage site is indicated by an arrow. The intracellular domain (NICD) contains various elements involved in transcriptional activation: a RAM domain, seven ankyrin repeats (ANK), a transactivation domain (TAD) and a PEST domain (P). TM, transmembrane domain. **(b,c)**Two models for the roles of Ofut1 in Notch trafficking. Each model is illustrated in a schematic cell that is shown as wild type on the left and *ofut1*mutant on the right, gray-shaded side. (b) Model 1: in the ER, newly synthesized, unfolded Notch (with the NECD in red and the NICD in white) becomes properly folded (NECD in green) and is *O*-fucosylated by Ofut1 (yellow diamond). It is then transported to the plasma membrane and adherens junctions (AJs, cyan) through the Golgi. In the absence of Ofut1, Notch remains unfolded and is retained in the ER. (c) Model 2: *O*-fucosylated Notch is first transported via the Golgi to the apical membrane and then transported to AJs by a transcytosis mechanism. In *ofut1*mutant cells, Notch goes to the membrane, is internalized and accumulates in an uncharacterized endocytic compartment.](jbiol68-1){#F1}

*O*-fucosylation of Notch is catalyzed by an *O*-fucosyltransferase (Pofut1 in mammals and Ofut1 in *Drosophila*) \[[@B7],[@B8]\] that uses GDP-fucose as a substrate. The *O*-fucose residue added by this *O*-fucosyltransferase can be further elongated by the addition of an *N*-acetylglucosamine by Fringe, an EGF-*O*-fucose β1,3 *N*-acetylglucosamyltransferase.

In *Drosophila*, the activity of Fringe is required for Notch signaling events involved in boundary formation, in which it reduces the affinity of Notch for Serrate while enhancing that for Delta \[[@B9],[@B10]\]. Given that Ofut1 is thought to be the sole enzyme that *O*-fucosylates Notch, the activity of Fringe is predicted to require the *O*-fucosylation activity of Ofut1. However, Ofut1 has additional functions, and other catalytic and non-catalytic activities have been proposed \[[@B8],[@B11]-[@B16]\]. These include roles in the folding of Notch in the endoplasmic reticulum (ER), in Notch-ligand binding and in endocytic trafficking of Notch. These different activities have been incorporated into two distinct models (Figure [1b](#F1){ref-type="fig"}). There are several observations that support each of these models, and there has been controversy about which one is correct. A recent paper in *BMC Biology*by Kenneth Irvine and colleagues (Okajima *et al*. \[[@B17]\]) provides compelling evidence in favor of one of these models.

The models and the supporting evidence
======================================

The first model \[[@B16]\] proposes that Ofut1 acts in the ER, where it performs two separable functions: to *O*-fucosylate Notch, thereby modulating Notch-ligand interaction, and to promote the correct folding of the extracellular domain of Notch (a non-catalytic function). The evidence in support of this model is as follows. First, Ofut1 is a soluble ER protein \[[@B16],[@B18]\]. It partially co-localizes with ER markers and acts, at least in part, in the ER: the carboxy-terminal extremity of Ofut1 contains a Lys-Asp-Glu-Leu (KDEL)-like motif that is dispensable for its catalytic activity but is required for both ER retention and function \[[@B16],[@B18]\]. Second, Ofut1 is required for secretion of Notch \[[@B16]\]. In *ofut1*mutant cells, the Notch protein accumulates in intracellular compartments marked by ER markers, and knockdown of Ofut1 using double-stranded RNA in cultured cells inhibits the secretion of a soluble version of the Notch extracellular domain (NECD) \[[@B15],[@B16]\]. This activity of Ofut1 does not require its *O*-fucosylation activity because expression of a mutant version of Ofut1 demonstrated to be catalytically dead (Ofut1^R275A^) mostly rescues the Notch localization defects. In addition, Ofut1 and Ofut1^R275A^both bind the NECD, and expression of Ofut1^R275A^in cultured cells can increase both the amount and the ligand-binding activity of secreted NECD \[[@B16]\]. Consistent with this proposed *O*-fucosylation-independent activity, Notch localizes at the cell cortex in GDP-mannose 4,6-dehydratase (*Gmd*) mutants \[[@B16]\], which contain no GDP-fucose \[[@B13]\], indicating that non-*O*-fucosylated Notch exits the ER.

Together, these results led to a simple model (model 1, Figure [1b](#F1){ref-type="fig"}) in which Ofut1 acts as an ER chaperone to promote the proper folding of the EGF repeats of Notch, thereby ensuring its correct cell-surface localization and ligand-binding activity.

The second model \[[@B12],[@B13]\] proposes that Ofut1 acts at two post-exocytosis steps in the trafficking of Notch: it regulates both the endocytosis of Notch \[[@B13]\] and its transcytosis from the apical plasma membrane to the adherens junctions (AJs) \[[@B12]\]. This model is supported by the following observations. First, Ofut1 is required for the proper distribution of Notch at AJs. In *ofut1*mutant cells, Notch does not accumulate at AJs but instead accumulates into intracellular \'dots\' that co-localize with ER markers only poorly \[[@B13]\]. In addition, surface-staining experiments indicate that a low level of Notch is also present at the surface of *ofut1*mutant cells \[[@B12]\]. These data were interpreted \[[@B12],[@B13]\] to suggest that Ofut1 is not required for the ER exit and cell-surface delivery of Notch.

Second, Ofut1 is required to regulate the endocytic trafficking of Notch, as monitored by antibody uptake. Anti-Notch antibodies are internalized in *ofut1*mutant cells, albeit at a lower level than in wild-type cells, but fail to accumulate in endosomes \[[@B13]\]. It is therefore proposed that Notch accumulates in an uncharacterized endocytic compartment in *ofut1*mutant cells. Finally, the second model is supported by the observation that a lower level of intracellular Notch is detected in *Gmd*mutant cells than in *ofut1*single-mutant or *ofut1*, *Gmd*double-mutant cells \[[@B12],[@B13]\]. This suggests that the endocytic activity of Ofut1 does not depend on its catalytic activity. In addition, the failure of Notch to localize at AJs in *Gmd*mutant cells is interpreted in the light of a speculative model of the transcytosis of Notch to suggest that Ofut1 acts in a catalysis-dependent manner to regulate the transcytosis of Notch \[[@B12]\]. We feel that this transcytosis model needs further experimental validation, so we will not detail the possible role of Ofut1 in this process further. We note, however, that this proposed role of Ofut1 in the transcytosis of Notch suggests that the *O*-fucosylation activity of Ofut1 is required for Fringe-independent signaling events.

Together, these observations suggest a model (model 2, Figure [1c](#F1){ref-type="fig"}) in which Ofut1 regulates the endocytic trafficking of Notch at a post-internalization step so that Notch accumulates in an undefined endocytic compartment in the absence of *ofut1*activity.

Thus, these two models offer two different interpretations of the cellular basis of the *ofut1*mutant phenotype: in model 1, the reason Notch does not signal is because it is trapped in the ER, whereas in model 2, it is because Notch accumulates in an undefined endocytic compartment with a low level of (inactive) Notch at the surface.

One implication of model 2 is that a fraction of Ofut1 must escape ER retention and act in the endocytic pathway. Consistent with this possibility, experiments using cultured cells indicate that a fraction of Ofut1 is secreted, interacts with the extracellular part of Notch at the cell surface, and is internalized in a Notch-dependent manner \[[@B13]\]. In addition, the Notch localization defects seen in cells treated with *ofut1*double-stranded RNA can be rescued by adding Ofut1-containing conditioned medium \[[@B13]\]. Whether this happens *in vivo*is not clear. Indeed, *ofut1*acts in a cell-autonomous manner to regulate the localization of Notch, arguing that secretion is not important in this regulation \[[@B12]\]. Moreover, the observed rescue of the *ofut1*knockdown phenotype by extracellular Ofut1 could also be consistent with model 1, given that endocytosed Ofut1 may be transported back into the ER.

Towards the end of a controversy
================================

So, how can we distinguish between the two models? Clearly, answering the following questions would help. Is Ofut1 required in the ER or in an endocytic compartment? Does Notch reach the cell surface in the absence of Ofut1 activity? Where does Notch accumulate in *ofut1*mutant cells? Is the *O*-fucosylation activity of Ofut1 required for proper Notch localization and activity? Or is it only required for Fringe-dependent signaling? Okajima *et al*. \[[@B17]\] have addressed these issues and provide compelling evidence in favor of model 1.

Okajima *et al*. \[[@B17]\] have shown that the *O*-fucosylation activity of *ofut1*is required for Fringe-dependent but not for Fringe-independent signaling events. They found that embryos lacking both maternal and zygotic contributions of *Gmd*develop into larvae, as *fringe*mutant embryos do. The complete loss of *ofut1*activity results in a strong phenotype mimicking a loss of *Notch* activity that is rescued to larval viability by the expression of Ofut1^R275A^. These data show that the *O*-fucosylation activity of Ofut1 is dispensable for Notch signaling in the embryo. This conclusion is entirely consistent with the observation that the activity of Fringe is dispensable in the embryo. It is therefore clear that non-fucosylated Notch can reach the cell surface and can signal.

Analysis by Okajima *et al*. \[[@B17]\] of the role of the *O*-fucosylation activity of *ofut1*during wing imaginal disc development led to identical conclusions. Although the loss of *ofut1*activity in clones leads to phenotypes mimicking a loss of *Notch*activity, expression of Ofut1^R275A^rescued Notch receptor activity in these *ofut1*mutant cells and led to phenotypes mimicking a loss of *fringe*activity. This confirms that non-fucosylated Notch can signal, and further indicates that the fucosylation activity of *ofut1*is required only for Fringe-dependent signaling events. This therefore implies that the transcytosis step of model 2, which was proposed to be dependent on Ofut1 catalytic activity, is not essential for Notch signaling.

Because the controversy over the exact role of Ofut1 is in part due to methodological differences between the various studies and also to technical limitations in subcellular localization analysis, Okajima *et al*. \[[@B17]\] also re-examined the localization of Notch in *ofut1*mutant cells using a detergent-free cell-surface staining protocol. A striking difference in surface staining was observed between wild-type and *ofut1*mutant cells. This convincingly shows that Notch is not present at detectable levels at the surface of mutant cells. This contradicts the results obtained by Sasaki *et al*. \[[@B12]\], who used a different protocol to assay the presence of Notch at the cell surface of *ofut1*mutant cells. Whether the difference in protocols accounts for these opposite conclusions remains to be addressed experimentally. The second piece of evidence in support of a cell surface accumulation of Notch in *ofut1*mutant cells comes from antibody uptake experiments showing that anti-Notch antibodies can be internalized by *ofut1*mutant cells \[[@B11]\]. However, as discussed by Okijama *et al*. \[[@B15]\], the low level of antibody uptake can probably be accounted for by the fluid-phase uptake of anti-Notch antibodies by live *ofut1*mutant cells, followed by the specific retention of internalized antibodies by Notch accumulating intracellularly. Together, the published data are best interpreted as concluding that Notch does not reach the cell surface in *ofut1*mutant cells.

Okajima *et al*. \[[@B17]\] next analyzed the distribution of Notch in *ofut1*mutant cells. Notch was shown to partially co-localize with four different ER markers that, in fact, show only partial co-localization among themselves. Thus, the only partially overlapping distribution of ER markers may explain the poor co-localization of Notch with the two ER markers seen by Sasamura *et al*. \[[@B13]\]. Okajima *et al*. \[[@B17]\] therefore propose that Notch accumulates in *ofut1*mutant cells in the ER, which is a heterogeneous organelle. Accordingly, Notch should co-localize better with the sum of the signals of the different ER markers. This remains to be tested.

In the light of these new data, it is clear that the *O*-fucosylation of Notch is primarily required for Fringe-dependent signaling events and that Ofut1 acts non-catalytically to regulate the exit of Notch from the ER. Thus, Ofut1 probably acts as a chaperone in the ER to promote the proper folding of the extracellular domain of Notch, as described in model 1. Although the catalytic and non-catalytic activities of Ofut1 can be experimentally uncoupled, it is attractive to speculate that the *O*-fucosylation activity of Ofut1 participates in the quality-control mechanism that ensures that only properly folded Notch exits the ER. Further analysis of the trafficking of non-fucosylated Notch, produced for instance by *Gmd*mutant cells, would help address this issue.
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